Craniosynostosis, the premature fusion of the top of the skull in infants, is caused by an abnormal excess of a previously unknown type of bone-forming stem cell, according to a preclinical study led by researchers at Weill Cornell Medicine.
Researchers have identified blood biomarkers that could help pediatricians quickly diagnose severe cases of COVID-19 as well as multisystem inflammatory syndrome, also known as MIS-C, which emerged during the pandemic.
Changes that are longer-lasting and distinct between crew members reveal new targets for aerospace medicine and can guide new missions, according to the results of a massive international research endeavor.
The bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to researchers at Weill Cornell Medicine, a discovery that opens up a new line of research on spinal disorders.
The College of Human Ecology has received a $10 million commitment from Joan Klein Jacobs ’54 and Irwin M. Jacobs ’54, BEE ’56 to support the college’s new Center for Precision Nutrition and Health.
A clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found remaining on the anti-obesity drug tirzepatide promoted additional weight loss and preserved improvements in metabolic and cardiovascular health.
An intercampus collaboration that aims to provide digital health care tools to pregnant refugee women, who are at elevated risk for pregnancy complications but often afraid to seek medical care, has been awarded a National Academy of Medicine Catalyst Prize.
A preclinical study by Weill Cornell Medicine investigators shows that a specific human genetic variant of a receptor that stimulates insulin release may help individuals be more resistant to obesity.
Nine students and recent graduates representing Cornell’s four contract colleges were selected to receive the 2024 State University of New York Chancellor’s Award for Student Excellence.